Dr. Katherine Marie Marshall, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 55021 M 51 N, Dowagiac, MI 49047 Phone: 269-782-3476 |
Smoke Family Vision Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 105 Pennsylvania Ave, Dowagiac, MI 49047 Phone: 269-782-7141 |
Dr. Alan K Montgomery, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 55021 M 51 N, Dowagiac, MI 49047 Phone: 269-782-3476 Fax: 269-782-6631 |
Southwest Vision Center Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 55021 M 51 N, Dowagiac, MI 49047 Phone: 269-782-3476 Fax: 269-782-6631 |
Alan K Montgomery Od Optometrist Medicare: Not Enrolled in Medicare Practice Location: 55021 M 51 N, Dowagiac, MI 49047 Phone: 269-782-3476 Fax: 269-782-6631 |
News Archive
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced today that the FDA warning letter issued to Genzyme addressing deficiencies related to Genzyme's Allston Landing manufacturing facility during an inspection performed in September and October 2008 has no foreseeable impact on the supply of Aldurazyme.
Kessler Foundation has been awarded a Spinal Cord Injury Model System grant valued at $2,300,000 over 5 years (2016-2021) from the National Institute on Disability, Independent Living, and Rehabilitation Research.
In direct response to recommendations made by a National Institutes of Health scientific consensus panel, the ECOG-ACRIN Cancer Research Group announced today the opening of E4112, a clinical trial for women with newly diagnosed ductal carcinoma in situ (DCIS) of the breast who, together with their doctors, will use the results of a magnetic resonance imaging (MRI) exam to determine whether to undergo a lumpectomy or a mastectomy.
Senesco Technologies, Inc. announced today that a high level of tumor eradication in a mouse model of human multiple myeloma was achieved with a combination of SNS01-T and lenalidomide.
A British company, Lifestyle Choices has launched the world's first publicly available triple-hormone ovarian reserve test, creating concerns that women may rely on it to estimate how many more years they can put off having children.
› Verified 9 days ago